Share Market News

Indian markets witnessed their sharpest single-day fall since late Sept on Dec 8, with the Nifty breaching the 26,000 mark. Despite the RBI’s 25 bps rate cut boosting domestic sentiment, what caused the plunge? Read more to find out.

India’s fuel demand hit a six-month high in November, driven by strong diesel, LPG and bitumen use, supported by transport, farming, infrastructure activity, and post-monsoon growth.

SEBI launches PaRRVA to verify past return claims, curb mis-selling, improve transparency, standardise performance data and strengthen oversight of advisers, analysts and market intermediaries.

As gold loans gain momentum, Keertana’s overhaul and Piramal’s renewed interest signal a market story worth watching. Explore the detailed report.

ITC Hotels’ stock will be in the spotlight as British American Tobacco (BAT) gets ready to sell a 7% stake through a ₹2,948 crore block deal. The transaction comes months after ITC Hotels’ listing post demerger.

ICICI Prudential AMC has set the price band for its Rs 10,603 crore IPO, kicking off a major week filled with key market triggers and global cues. Read the complete report.

Cochin Shipyard has secured a major international order from Svitzer to build advanced electric tugs, strengthening its position in green maritime manufacturing. Read the full story here

Gold prices inched higher on Dec 8, led by the softening US dollar and rising market confidence in a Federal Reserve rate cut this week. Are investors shifting toward non-yielding assets? Read ahead to find out!

Ola Electric begins mass deliveries of the S1 Pro+ using its new 4680 Bharat Cell, aiming to cut costs, boost performance, scale production, and strengthen EV growth.

On Dec 8, oil prices climbed to two-week highs, supported by the US Fed Reserve rate cut expectations and intensifying geopolitical risks. Why do markets anticipate a monetary boost to demand in a volatile trading environment? Read ahead to find out more.

Biocon Pharma received US FDA tentative approval for carbidopa–levodopa extended-release capsules, boosting its US generics pipeline amid a growing global Parkinson’s treatment market.